203 related articles for article (PubMed ID: 30951520)
1. A non-natural nucleotide uses a specific pocket to selectively inhibit telomerase activity.
Hernandez-Sanchez W; Huang W; Plucinsky B; Garcia-Vazquez N; Robinson NJ; Schiemann WP; Berdis AJ; Skordalakes E; Taylor DJ
PLoS Biol; 2019 Apr; 17(4):e3000204. PubMed ID: 30951520
[TBL] [Abstract][Full Text] [Related]
2. Effects of reverse transcriptase inhibitors on telomere length and telomerase activity in two immortalized human cell lines.
Strahl C; Blackburn EH
Mol Cell Biol; 1996 Jan; 16(1):53-65. PubMed ID: 8524329
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of telomerase activity and cell proliferation by a reverse transcriptase inhibitor in gynaecological cancer cell lines.
Murakami J; Nagai N; Shigemasa K; Ohama K
Eur J Cancer; 1999 Jun; 35(6):1027-34. PubMed ID: 10533489
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms of nucleotide selection by telomerase.
Schaich MA; Sanford SL; Welfer GA; Johnson SA; Khoang TH; Opresko PL; Freudenthal BD
Elife; 2020 Jun; 9():. PubMed ID: 32501800
[TBL] [Abstract][Full Text] [Related]
5. Telomerase inhibition using azidothymidine in the HT-29 colon cancer cell line.
Brown T; Sigurdson E; Rogatko A; Broccoli D
Ann Surg Oncol; 2003 Oct; 10(8):910-5. PubMed ID: 14527910
[TBL] [Abstract][Full Text] [Related]
6. Telomerase-inhibitory effects of the triphosphate derivatives of some biologically active nucleosides.
Yamaguchi T; Takayama Y; Saito M; Ishikawa F; Saneyoshi M
Nucleic Acids Res Suppl; 2001; (1):211-2. PubMed ID: 12836339
[TBL] [Abstract][Full Text] [Related]
7. [Azidothymidine, blocking telomerase functioning, shortens telomeric repeats in transformed human cells].
Egorov EE; Akhmalisheva AKh; Smirnova IuB; Shinkarev DB; Chernov DN; Zelenin AV; Kraevskiĭ AA
Genetika; 1997 Oct; 33(10):1444-6. PubMed ID: 9445812
[TBL] [Abstract][Full Text] [Related]
8. Modeling of Plasmodium falciparum Telomerase Reverse Transcriptase Ternary Complex: Repurposing of Nucleoside Analog Inhibitors.
Mohanty P; Gupta A; Bhatnagar S
Assay Drug Dev Technol; 2015 Dec; 13(10):628-37. PubMed ID: 26690766
[TBL] [Abstract][Full Text] [Related]
9. Irreversible telomere shortening by 3'-azido-2',3'-dideoxythymidine (AZT) treatment.
Gomez DE; Tejera AM; Olivero OA
Biochem Biophys Res Commun; 1998 May; 246(1):107-10. PubMed ID: 9600076
[TBL] [Abstract][Full Text] [Related]
10. Cyclic induction of senescence with intermittent AZT treatment accelerates both apoptosis and telomere loss.
Ji HJ; Rha SY; Jeung HC; Yang SH; An SW; Chung HC
Breast Cancer Res Treat; 2005 Oct; 93(3):227-36. PubMed ID: 16132531
[TBL] [Abstract][Full Text] [Related]
11. In vitro and ex vivo inhibition of human telomerase by anti-HIV nucleoside reverse transcriptase inhibitors (NRTIs) but not by non-NRTIs.
Hukezalie KR; Thumati NR; Côté HC; Wong JM
PLoS One; 2012; 7(11):e47505. PubMed ID: 23166583
[TBL] [Abstract][Full Text] [Related]
12. The effects of nucleoside analogs on telomerase and telomeres in Tetrahymena.
Strahl C; Blackburn EH
Nucleic Acids Res; 1994 Mar; 22(6):893-900. PubMed ID: 8152919
[TBL] [Abstract][Full Text] [Related]
13. Pharmacodynamic studies (PD) of didanosine (ddI) alone and in combination with azidothymidine (AZT) in human T-cells; a stochastic biochemical approach to antiretroviral nucleoside drug combination in inhibiting HIV-reverse transcriptase (RT).
Periclou AP; Nandy P; Avramis VI
In Vivo; 2000; 14(3):377-88. PubMed ID: 10904870
[TBL] [Abstract][Full Text] [Related]
14. Structural basis for telomerase catalytic subunit TERT binding to RNA template and telomeric DNA.
Mitchell M; Gillis A; Futahashi M; Fujiwara H; Skordalakes E
Nat Struct Mol Biol; 2010 Apr; 17(4):513-8. PubMed ID: 20357774
[TBL] [Abstract][Full Text] [Related]
15. Structural Basis of Telomerase Inhibition by the Highly Specific BIBR1532.
Bryan C; Rice C; Hoffman H; Harkisheimer M; Sweeney M; Skordalakes E
Structure; 2015 Oct; 23(10):1934-1942. PubMed ID: 26365799
[TBL] [Abstract][Full Text] [Related]
16. Structure of the Tribolium castaneum telomerase catalytic subunit TERT.
Gillis AJ; Schuller AP; Skordalakes E
Nature; 2008 Oct; 455(7213):633-7. PubMed ID: 18758444
[TBL] [Abstract][Full Text] [Related]
17. 3'-Azido-2',3'-dideoxynucleoside 5'-triphosphates inhibit telomerase activity in vitro, and the corresponding nucleosides cause telomere shortening in human HL60 cells.
Liu X; Takahashi H; Harada Y; Ogawara T; Ogimura Y; Mizushina Y; Saneyoshi M; Yamaguchi T
Nucleic Acids Res; 2007; 35(21):7140-9. PubMed ID: 17942424
[TBL] [Abstract][Full Text] [Related]
18. Crystallographic Studies of Telomerase.
Hoffman H; Skordalakes E
Methods Enzymol; 2016; 573():403-19. PubMed ID: 27372764
[TBL] [Abstract][Full Text] [Related]
19. [Suppression of alternative telomere lengthening in cancer cells with reverse transcriptase inhibitors].
Bondarev IE; Khavinson VK
Adv Gerontol; 2016; 29(2):218-221. PubMed ID: 28514537
[TBL] [Abstract][Full Text] [Related]
20. [Effect of reverse transcriptase inhibitors on telomerase function in immortal murine fibroblasts].
Egorov EE; Chernov DN; Akimov SS; Bol'sheva NL; Kraevskiĭ AA; Zelenin AV
Mol Biol (Mosk); 1997; 31(1):130-6. PubMed ID: 9173232
[No Abstract] [Full Text] [Related]
[Next] [New Search]
